Vitamin B12: a Biological Marker of Systemic Disease or Infection Flare-up in Patients Treated with Tocilizumab?

NCT06654154 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
56
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Clermont-Ferrand